Jet.AI Announces Letter of Intent for New Merger and related Spin-Off of Data Center Business

Stock Information for Y-mAbs Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Y-mAbs Therapeutics Inc.

Jet.AI Highlights Strategic Value of AI Data Center Portfolio Amid Surging Demand for Powered Land and Early-Stage Infrastructure Assets
Jet.AI Plugs into Alberta's AI Boom with Investment in 200MW+ Natural Gas Powered Data Center
UPDATE: Jet.AI Shareholders to Receive $10 Per Share in Stock and Cash as Company Signs Letter of Intent for a New $300 Million Reverse Takeover
Jet.AI Closes Transaction with flyExclusive, Advancing Transition to a Pure-Play AI Infrastructure
Jet.AI Stockholders Approve Proposed flyExclusive Transaction
flyExclusive Reaches Final Approval Milestone for Jet.AI Transaction, Positioning Company for Continued Growth
Jet.AI Stockholder Votes Exceed Majority Threshold for flyExclusive Transaction
flyExclusive Reaffirms Strategic Priorities and Provides Update on Pending Jet.AI Transaction

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.